ONVO - MCAP CO - Organovo Holdings, Inc.

Organovo Holdings, Inc. (ONVO) is scaling its bioprinting platforms to validate liver pathology therapies by integrating them into the R&D processes of global pharmaceutical behemoths. This price chart helps track the asset, which has a market capitalization of . The firm's leadership is driven by the NovoGen innovation, which reduces drug development costs. Revenues are based on the creation of living tissues and the provision of diagnostic ancillary services.

Organovo Holdings, Inc. (ONVO) creates innovative 3D bioprinted tissues by merging advanced engineering with biology. The analysis of the issuer's market capitalization on the GURU.Markets platform reflects the aggregate market value of all the company's shares. This indicator measures market demand, allowing an investor to calculate the asset's portfolio weighting. For this startup, the trend of this metric correlates directly with the success of scientific grants and the value of intellectual capital. The curve's trend determines the viability of the business model and the risk of bankruptcy.